News Search Results
Oct 13, 2025, 15:03 ET Algae Products Market to Reach USD 9.7Billion by 2032, Growing At An 7% CAGR - Credence Research
Development of Novel Algae Strains and Bioengineering Applications Advances in genetic research, synthetic biology, and strain optimization technologies are enabling the development of novel algae varieties with enhanced productivity, targeted nutritional profiles,
More news about: Credence Research Inc.
Oct 09, 2025, 06:04 ET Beijing Review: Rivers, Rice and Revolution
years, Dafeng Port has explored a "green electricity + hydrogen" development model, fostering industries such as green hydrogen and marine and synthetic biology, and supporting the transition of traditional sectors like steel, paper and chemicals. Muhammad Asghar, chief reporter
More news about: Beijing Review
Sep 30, 2025, 11:45 ET Made Scientific and Syenex Forge Technology Partnership to Transform T Cell Therapy Manufacturing
2025 /PRNewswire/ -- Made Scientific, a leading cell therapy contract development and manufacturing organization (CDMO) and Syenex, a synthetic biology company specializing in best-in-class targeted delivery technologies, today announced a technology partnership to advance the scalability and
More news about: Made Scientific, Inc.
Sep 30, 2025, 09:00 ET K18 and Future Society Launch First-Ever Biotech Beauty Collaboration With Limited-Edition Floating Forest Hair Mask
repair service that protects, strengthens, and preserves hair health through even extreme salon services. As the leader in synthetic biology for beauty, K18 sets itself apart by addressing hair health from the inside out, rather than relying on surface-level solutions. With over 20
More news about: K18 Biomimetic Hairscience
Sep 25, 2025, 09:37 ET The FDA Granted Orphan Drug Designation to Biostar Pharma's Utidelone for the Treatment of Pancreatic Cancer
Biostar Pharma, Inc., the US wholly-owned subsidiary of Beijing Biostar Biopharmaceutical Co., Ltd. ("Biostar," stock code: 2563.HK) which is a synthetic biology driven biopharma company focusing on the discovery, development and commercialization of innovative oncology drugs, is pleased to announce that
More news about: Biostar Pharma, Inc.
Sep 24, 2025, 09:00 ET Hood College Receives NSF Grant for Biotechnology Training Program
Foundation's Experiential Learning for Emerging and Novel Technologies (ExLENT) program to launch the Innovative, Immersive Training Program in Synthetic Biology and Biomanufacturing.
More news about: Hood College
Sep 18, 2025, 09:20 ET AIChE Awards Its 2025 Langer Prize to Mark Blenner of the University of Delaware
efficiently process mixed, uncleaned plastic waste and be deployed in decentralized systems, making them attractive for plastic upcycling. Synthetic biology can enhance these solutions for industrial applications. Blenner's blue-sky idea was selected from a global candidate pool with
More news about: American Institute Of Chemical Engineers
Sep 17, 2025, 12:00 ET Terra Oleo Emerges from Stealth with US$3.1M in Funding and Breakthrough Energy Fellow Selection to Reinvent Fats and Oils
precision fermentation to transform agro-industrial waste into sustainable palm oil ingredients and cocoa butter alternatives. Backed by deep synthetic biology and microbial engineering expertise, the platform delivers tailored lipid profiles for high-value palm and cocoa applications, while eliminating
More news about: Terra Oleo
Sep 15, 2025, 08:00 ET Biostar Pharma Successively Achieved First Patient Dosing for Two Phase II/III Multiregional Clinical Trials of Utidelone Capsule (UTD2)
/PRNewswire/ -- Biostar Pharma, Inc., the US subsidiary of Beijing Biostar Pharmaceuticals Co., Ltd. ("Biostar", Stock Code: 2563.HK) which is a synthetic biology driven biopharma company focusing on the discovery, development and commercialization of innovative oncology drugs, is pleased to announce that
More news about: Biostar Pharma, Inc.
Sep 12, 2025, 10:01 ET Ligase Enzymes Market worth US$0.36 billion by 2030 with 6.8% CAGR | MarketsandMarkets™
growing due to the rising demand for molecular diagnostics, the increasing adoption of next-generation sequencing (NGS), expanding applications in synthetic biology, and continuous advancements in enzyme engineering. The growing use of ligases in molecular diagnostics, particularly in cancer genomics, infectious
More news about: MarketsandMarkets
Sep 08, 2025, 12:07 ET Cerillo to launch Rayo: Next-Gen Multiwavelength Microplate Reader at Analytica USA 2025
microplate readers, the Duet® co-culture system, Labrador® software, and Canopy® wireless accessories, Cerillo empowers labs across microbiome, synthetic biology, environmental, and pharmaceutical research to conduct high-quality science anywhere, whether in the field or in restricted spaces. Rayo
More news about: Cerillo
Sep 08, 2025, 10:33 ET Liquid Biopsy Market to Reach USD 30.65 Billion by 2035, with CAGR 9.41% Driven by Rising Cancer Burden and Demand for Non-Invasive Diagnostics - Vantage Market Research
Annual Growth Rate) of 12.61% between 2025 and 2035.Synthetic Biology Market: The global Synthetic Biology Market is valued at USD 16.94 Billion in 2024 and is projected
More news about: Vantage Market Research
Aug 26, 2025, 08:34 ET OODAcon 2025: Accelerating Disruptive Technologies
scenario-driven update on the world's most urgent risks.Biotech Warfare and Biosecurity in the Age of AI: Navigating the risks of synthetic biology and dual-use research.Art and Privacy in the Age of AI: Protecting civil liberties and resilience amid ubiquitous surveillance.Moving
More news about: OODA LLC
Aug 21, 2025, 08:30 ET AI in Molecular Biology: Revolutionizing the Future of Biotech, Upcoming Webinar Hosted by Xtalks
simplify research processes in biotechnology and life sciences. Attendees will learn how accelerated innovation facilitates breakthroughs in synthetic biology, drug discovery, gene therapy and other cutting-edge fields. The featured speaker will share how data-driven decisions empower scientists with
More news about: Xtalks
Aug 20, 2025, 10:15 ET Human Microbiome Market worth $7.09 billion by 2031 with 31.0% CAGR | MarketsandMarkets™
different stages of life or health needs. The microbiome innovation of IFF is supported by ongoing collaborations and a broader portfolio in synthetic biology, enabling the development of functional ingredients across consumer and health product categories. For more information,
More news about: MarketsandMarkets
Aug 20, 2025, 08:32 ET Quintara Biosciences Launches Whole Plasmid Sequencing - Express (WPS-Express) Across Four U.S. Sites
length or data quality. Combined with localized logistics support, the service is ideal for fast-paced research settings in molecular cloning, synthetic biology, and antibody discovery. Quintara Biosciences is a nationwide provider of genomics and molecular biology services, offering sequencing,
More news about: Quintara Biosciences
Aug 20, 2025, 08:01 ET Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Partner to Deploy AI-driven Lab-in-the-loop Workflows Across the Biopharma Industry
business opportunities, including with respect to our solutions and tools offerings, (iv) the risk of downturns in demand for products using synthetic biology, (v) the uncertainty regarding the demand for passive monitoring programs and biosecurity services, (vi) changes to the biosecurity industry,
More news about: Ginkgo Bioworks
Aug 17, 2025, 08:01 ET GenScript Biotech Demonstrates Profitable Scale and Strategic Leadership in H1 2025, Establishing Clear Industry Leadership Through Accelerated Growth and Innovation
into future revenue streams and underline long-term growth potential. Industrial synthetic biology products' Market Leadership and Product Innovation Bestzyme, Industrial synthetic biology products unit, grew its revenue by 8.4%, driven by market share gains for its innovative enzyme
More news about: GenScript Biotech Corporation
Aug 12, 2025, 09:00 ET Closed Loop Partners Advances Major Progress for the Circular Economy, With Portfolio Companies Keeping Over $5 Billion of Materials and Products in Circulation Through Local and Regional Investments and Infrastructure Builds
firm, together with its partners, has achieved several milestones, including: 90+ investments in solutions ranging from synthetic biology and regional recycling to advanced material recovery technologies through venture capital, private equity, and catalytic capital & private
More news about: Closed Loop Partners
Aug 12, 2025, 08:01 ET Ginkgo Automation Appoints Brian O'Sullivan as Head of Commercial to Accelerate External Growth
business opportunities, including with respect to our solutions and tools offerings, (iv) the risk of downturns in demand for products using synthetic biology, (v) the uncertainty regarding the demand for passive monitoring programs and biosecurity services, (vi) changes to the biosecurity industry,
More news about: Ginkgo Bioworks
Aug 07, 2025, 17:01 ET Ginkgo Bioworks Reports Second Quarter 2025 Financial Results
business opportunities, including with respect to our solutions and tools offerings, (iv) the risk of downturns in demand for products using synthetic biology, (v) the uncertainty regarding the demand for passive monitoring programs and biosecurity services, (vi) changes to the biosecurity industry,
More news about: Ginkgo Bioworks
Aug 05, 2025, 11:44 ET Cell Line and Membrane Market to Grow at 12.5% CAGR Through 2030
startups: Bit.bio: Founded by the University of Cambridge, bit.bio is a human synthetic biology startup that specializes in coding cells for novel cures by using its opti-ox technology to produce scalable and reliable human cells for cell
More news about: BCC Research LLC
Jul 31, 2025, 10:15 ET Biopharmaceuticals Market is Estimated to Reach USD 948.6 Bilion by 2032 | SkyQuest Technology Consulting
Pharmaceuticals Sector: Synthetic Biology Market - https://www.skyquestt.com/report/synthetic-biology-marketInterventional Oncology Market -
More news about: SkyQuest Technology
Jul 30, 2025, 09:01 ET Ginkgo to Deploy Modular Automation Technology to the Environmental Molecular Sciences Laboratory (EMSL) at Pacific Northwest National Labs (PNNL) to Accelerate Microbial Research for the Bioeconomy
business opportunities, including with respect to our solutions and tools offerings, (iv) the risk of downturns in demand for products using synthetic biology, (v) the uncertainty regarding the demand for passive monitoring programs and biosecurity services, (vi) changes to the biosecurity industry,
More news about: Ginkgo Bioworks
Jul 30, 2025, 08:00 ET CDI Labs Launches Pan-isotype Analysis of Serum Autoantibodies to Unlock Critical New Insights Into Humoral Immunity
sequencing.About CDI Laboratories, Inc. CDI Labs is a specialized CRO and lab services proteomics company. Powered by cutting-edge synthetic biology platforms, CDI Labs has generated the world's largest collection of proteomes, and in doing so has built a team with deep proteomics bench expertise.
More news about: CDI LABORATORIES, INC.